Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIFLU in critically ill adults with severe influenza
2024-516058-23-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oseltamivir and acetaminophen in influenza, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Days alive without invasive mechanical ventilation at day 28. Started Dec 2023; status: completed.
02
Drugs
oseltamiviracetaminophen
03
Conditions
influenza
Beyond the preview
Go deeper on 2024-516058-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516058-23-00.